Business Context and Reporting Period
This Form 6-K is filed by Midatech Pharma PLC (noted as Biodexa Pharmaceuticals Plc in request metadata) for the month of October 2019, with a specific filing date of October 28, 2019. The registrant is a Foreign Private Issuer based in Cardiff, United Kingdom, filing under Rule 13a-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely as a vehicle to submit a press release regarding corporate governance matters rather than financial performance.
Material Changes
The filing incorporates by reference a press release dated October 28, 2019, titled "Total Voting Rights". No financial material changes or operational updates are detailed in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting rights information.
Investor Verification Checklist
- Verify the specific details of the "Total Voting Rights" press release (Exhibit 99.1) to understand the impact on shareholder structure.
- Confirm the correct registrant name, as the filing header lists "Midatech Pharma PLC" while the request metadata references "Biodexa Pharmaceuticals Plc".
- Note that this filing contains no financial data; refer to the most recent Form 20-F for financial metrics.